Systematic Review
Published on 07 Apr 2022
Prognostic Value of Elevated Pre-treatment Serum CA-125 in Epithelial Ovarian Cancer: A Meta-Analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.868061
- 3,744 views
- 16 citations
Type at least 3 characters
907 articles
Articles
Original Research
Published on 06 Apr 2022
Gynecologic Oncology and Inclusion of Women Into the Surgical Workforce: The Canary in This Coal Mine
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.789910
- 3,512 views
- 5 citations
Original Research
Published on 06 Apr 2022
Goal-Directed Intraoperative Fluid Therapy Benefits Patients Undergoing Major Gynecologic Oncology Surgery: A Controlled Before-and-After Study
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.833273
- 2,573 views
- 6 citations
Editorial
Published on 05 Apr 2022
Editorial: Advances of Targeted Therapy in Gynecologic Malignancies
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.887773
- 1,570 views
Original Research
Published on 05 Apr 2022
Cervical Carcinoma: Evaluation Using Diffusion MRI With a Fractional Order Calculus Model and its Correlation With Histopathologic Findings
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.851677
- 1,731 views
- 3 citations
Systematic Review
Published on 31 Mar 2022
Association Between Endometriosis and Prognosis of Ovarian Cancer: An Updated Meta-Analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.732322
- 3,636 views
- 9 citations
Original Research
Published on 30 Mar 2022
Risk Factor Assessment of Lymph Node Metastasis in Patients With FIGO Stage IB1 Cervical Cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.809159
- 1,769 views
- 4 citations
Original Research
Published on 29 Mar 2022
Machine Learning-Assisted Ensemble Analysis for the Prediction of Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.817250
- 2,472 views
- 2 citations
Editorial
Published on 28 Mar 2022
Editorial: Harnessing DNA Damage Response in Gynecologic Malignancies
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.882925
- 1,139 views
Original Research
Published on 25 Mar 2022
The Therapeutic Effects of DDP/CD44-shRNA Nanoliposomes in AMF on Ovarian Cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.811783
- 2,428 views
- 9 citations
Original Research
Published on 24 Mar 2022
Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.800957
- 1,317 views
Original Research
Published on 23 Mar 2022
Incidence and Survival of Multiple Primary Cancers in US Women With a Gynecologic Cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.842441
- 3,223 views
- 3 citations
Methods
Published on 23 Mar 2022
Effectiveness and Safety of Niraparib as Neoadjuvant Therapy in Advanced Ovarian Cancer With Homologous Recombination Deficiency (NANT): Study Protocol for a Prospective, Multicenter, Exploratory, Phase 2, Single-Arm Study
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.852772
- 5,158 views
- 10 citations
Review
Published on 23 Mar 2022
Deep Infiltrating Endometriosis Malignant Invasion of Cervical Wall and Rectal Wall With Lynch Syndrome： A Rare Case Report and Review of Literature
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.832228
- 5,280 views
- 13 citations
Original Research
Published on 23 Mar 2022
Development and External Validation of a Novel Model for Predicting Postsurgical Recurrence and Overall Survival After Cytoreductive R0 Resection of Epithelial Ovarian Cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.859409
- 2,018 views
- 1 citation
Original Research
Published on 22 Mar 2022
Comprehensive Molecular Analyses of a TNF Family-Based Gene Signature as a Potentially Novel Prognostic Biomarker for Cervical Cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.854615
- 3,532 views
- 4 citations